We are live on
!
Find out more
HAIM
Hunter Associates Investment Management Portfolio holdings
AUM
$868M
1-Year Est. Return
32.25%
This Fund
S&P 500
This Quarter
Est. Return
+3.8%
1 Year Est. Return
+32.25%
3 Year Est. Return
+76.06%
5 Year Est. Return
+90.53%
10 Year Est. Return
+362.05%
AUM
$238M
AUM Growth
+$3.39M
(+1.4%)
Cap. Flow
-$3.68M
Cap. Flow
% of AUM
-1.55%
Top 10 Holdings %
Top 10 Hldgs %
30.82%
Holding
164
New
8
Increased
30
Reduced
66
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$1.83M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$421K |
| 3 |
Iron Mountain
IRM
|
+$365K |
| 4 |
NEOS
Neos Therapeutics, Inc
NEOS
|
+$310K |
| 5 |
TRIB
Trinity Biotech
TRIB
|
+$301K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.45M |
| 2 |
Procter & Gamble
PG
|
+$1.01M |
| 3 |
Amgen
AMGN
|
+$509K |
| 4 |
IBM
IBM
|
+$451K |
| 5 |
T. Rowe Price
TROW
|
+$435K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.26% |
| 2 | Technology | 21.27% |
| 3 | Industrials | 14.77% |
| 4 | Consumer Staples | 9.04% |
| 5 | Energy | 8.11% |
Similar funds
ICCFIA
BGC
HP
RWM
EI
NEPWA
MCM
PLFA
Hunter Associates Investment Management's Q1 2017 Portfolio in Review
As of Q1 2017, Hunter Associates Investment Management held 164 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Hunter Associates Investment Management's Q1 2017 filing shows 8 new, 30 increased, 66 reduced and 3 closed positions. Its largest new stake was Endo International plc: 33,900 shares worth $378K. The largest sale was Pfizer, an estimated $1.45M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.
- Hunter Associates Investment Management's largest Q1 2017 buy was Endo International plc: 33,900 shares worth $378K.
- Hunter Associates Investment Management added most to Weyerhaeuser in Q1 2017, an estimated $1.83M increase.
- Hunter Associates Investment Management's biggest Q1 2017 reduction was Pfizer, cutting an estimated $1.45M.
- Hunter Associates Investment Management fully exited NextGen Healthcare, Inc. Common Stock in Q1 2017, selling an estimated $263K.
- Hunter Associates Investment Management's ten largest holdings make up 31% of its $238M portfolio in Q1 2017.
- Hunter Associates Investment Management opened 8 new positions and closed 3 in Q1 2017.
- Hunter Associates Investment Management's portfolio value rose 1.4% quarter-over-quarter to $238M.
Based on Hunter Associates Investment Management's 13F filing for Q1 2017, filed 10 May 2017.